Skip to main content
. 2015 Oct 13;17(1):120–132. doi: 10.1208/s12249-015-0417-7

Fig. 6.

Fig. 6

PXRD profiles from samples stored at 40°C/43%RH for 6 months (from bottom to top) of GRIS crystalline drug (Inline graphic), HME processed dispersions (Inline graphic), and KSD processed dispersions (Inline graphic) (from 10% to 40% drug load) in a (PVP K17) and c (HPMC E5). KSD processed dispersions of PVPK30 (Inline graphic) and PVP K90 (Inline graphic) (from 10% to 40% drug load) in b, and KSD processed dispersions of HPMC E15 (Inline graphic) and HMPC E50 (Inline graphic) (from 10% to 40% drug load) in d. Areas of observed trace crystallinity are marked with arrows